GET THE APP

Synthesis, In Silico and In Vitro anticancer screening of some novel nitrogen bridged imidazopyrimidines | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Synthesis, In Silico and In Vitro anticancer screening of some novel nitrogen bridged imidazopyrimidines

Author(s): K. Sruthi, M. Sumakanth, Mahendra Kumar C. B. and Naresh K

Novel derivatives of Imidazo[1,2-a] pyrimidines(3a-3n) were synthesized by the ring opening of 4-Arylidine-2- Phenyl-Oxazole-5-Ones with 2-Amino Pyrimidines. The compounds obtained were identified and characterized by their physical, spectral and elemental analysis data. In vitro anti-proliferative activity of some of the synthesized compounds was carried out on A549 (Lung cancer) cell lines by employing MTT assay. In silico screening of these derivatives was carried out by molecular docking techniques using Schrodinger(Glide) and Auto dock softwares to find potent B-Raf Kinase inhibitors among the synthesized compounds. It was observed that compounds 3d and 3h with IC 50 values < 10 μM demonstrated good anti-proliferative activity on cell lines and are comparable with the respective docking G-Scores and mmGBSA values.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry